Novel Cyclic Peptides for Targeting EGFR and EGRvIII Mutation for Drug Delivery

• Asıl Yazarlar: Olga Furman (Yazar), Alisa Zaporozhets (Yazar), Dror Tobi (Yazar), Andrii Bazylevich (Yazar), Michael A. Firer (Yazar), Leonid Patsenker (Yazar), Gary Gellerman (Yazar), Bat Chen R. Lubin (Yazar)
• Materyal Türü: Kitap
• Baskı/Yayın Bilgisi: MDPI AG, 2022-07-01T00:00:00Z.
• Konular: article
• Online Erişim: Connect to this object online.

The epidermal growth factor-epidermal growth factor receptor (EGF-EGFR) pathway has become the main focus of selective chemotherapeutic intervention. As a result, two classes of EGFR inhibitors have been clinically approved, namely monoclonal antibodies and small molecule kinase inhibitors. Despite...